Originally developed by Singulex®, Inc., Single Molecule Counting (SMC®) technology with the SMCxPRO® platform enables researchers to measure femtogram levels of biomarkers and better understand the clinical relevance from healthy to disease. Learn more about SMC® technology, immunoassay kits, and how you can design your own custom assay to meet your critical research needs.
Providing maximum immunoassay performance while following a workflow similar to traditional ELISA technology, SMC® technology combines a unique assay elution step and robust digital counting to achieve improved signal-to-noise ratios over traditional immunoassay technologies. The SMC® technology thus provides enhanced quantification at both low and high levels of expression on one complete system. The SMCxPRO® instrument captures the sum of all digital events counted above the background threshold. The digital event algorithm of the SMCxPRO® instrument computes digital events across a spectrum of time series for a single standard. The digital counting of molecules thus improves the assay sensitivity and extends the assay dynamic range beyond what can be achieved with traditional methods.
A comprehensive set of criteria evaluating ultimate performance are used to qualify verified SMC® immunoassays, including:
Browse all the ways researchers are using SMC® technology including drug development, neuroscience, cardiotoxicity, immunology research, and more.
See why choosing ultrasensitive SMC® technology can help you take a deeper look at your research to discover even more.
SMC® assays are run on the state-of-the-art SMCxPRO® detection instrument. Discover more about this ultrasensitive immunoassay platform.
View info on ancillary kits and equipment for SMC® assays that help optimize your workflows.
Explore more about our Custom Assay Development & Innovation (CADI) services and request more info.
Get tips and tricks for running SMC® assays straight from the experts.
To continue reading please sign in or create an account.Don't Have An Account?